TRS-008

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameTRS-008
Drug Alias NameTRS-008FIT012
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungCarcinoma, Transitional Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Teruisi Pharmaceutical IncShanghai Epimab Biotherapeutics, Inc
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Teruisi Pharmaceutical IncShanghai Epimab Biotherapeutics, Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungCarcinoma, Transitional Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A